参考文献/References:
[1] Molnar J, Yu S, Mzhavia N,et al. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice[J].Circ Res,2005,96(11):1178-1184.
[2] Nakashima M, Toyono T, Akamine A,et al. Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis[J].Mech Dev,1999,80(2):185-189.
[3] McPherron AC, Lawler AM, Lee SJ. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11[J].Nat Genet,1999,22(3):260-264.
[4] Esquela AF, Lee SJ. Regulation of metanephric kidney development by growth/differentiation factor 11[J].Dev Biol,2003,257(2):356-370.
[5] Katsimpardi L, Litterman NK, Schein PA,et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J].Science,2014,344(6184):630-634. DOI: 10.1126/science.1251141.
[6] Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis[J].Am J Cardiol,2007,99(4A):6B-14B.
[7] Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease[J].Circulation,2003,108(17):2054-2059.
[8] Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine[J].Nature,1988,333(6174):664-666.
[9] Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology[J].Pharmacol Rev,1991,43(2):109-142.
[10] Oemar BS, Tschudi MR, Godoy N,et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis[J].Circulation,1998,97(25):2494-2498.
[11] Oh SP, Yeo CY, Lee Y, et al. Activin type ⅡA and ⅡB receptors mediate Gdf11 signaling in axial vertebral patterning[J].Genes Dev,2002,16(21):2749-2754.
[12] Andersson O, Reissmann E, Ibáez CF. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis[J].EMBO Rep,2006,7(8):831-837.
[13] Loffredo FS, Steinhauser ML, Jay SM,et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy[J].Cell,2013,153(4):828-839.DOI: 10.1016/j.cell.2013.04.015.
[14] Heidecker B, Olson K, Beatty A. Low levels of growth differentiation factor 11 and high levels of its inhibitor follistatin-like 3 are associated with adverse cardiovascular outcomes in humans[J]. J Am Coll Cardiol,2015,65(10S):A999.
[15] Olson KA, Beatty AL, Heidecker B,et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts[J].Eur Heart J, 2015,36(48):3426-3434. DOI: 10.1093/eurheartj/ehv385.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(02):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(02):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(02):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(02):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(02):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[7]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(02):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[8]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(02):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[9]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(02):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
[10]韩丽萍,陈莉明.GLP-1的神经保护作用[J].国际内分泌代谢杂志,2016,36(05):316.[doi:10.3760/cma.j.issn.1673-4157.2016.05.08]
Han Liping,Chen Liming.Neuroprotective actions of glucagon-like peptide-1[J].International Journal of Endocrinology and Metabolism,2016,36(02):316.[doi:10.3760/cma.j.issn.1673-4157.2016.05.08]